Skip to main content

Bevacizumab (Avastin®) (mAb-based)

$1,110.00
SKU:
TM09011
Bulk Pricing:
Buy in bulk and save
Adding to cart… The item has been added

Immunoguide® Enzyme immunoassay (ELISA) test kit for the determination of free Bevacizumab (Avastin®) in serum and plasma.<br><br>

The drug Bevacizumab (trade name Avastin®) is a recombinant human IgG1:ƙ monoclonal antibody specific for all human vascular endothelial growth factor-A (VEGF-A) isoforms and it has been approved by the FDA as a first-line treatment for metastatic colorectal cancer in combination with chemotherapy. Furthermore, VEGF is implicated in intraocular neovascularization associated with diabetic retinopathy and age-related macular degeneration.<br><br>

The specificity of this test system is achieved by using a monoclonal antibody named "MAY-2B5" for the coating of the microtiter plate. This antibody is specific for Bevacizumab only and does not cross react with other VEGF catchers. For research use only, not for use in diagnostic procedures.

Assay Description:
1 hour incubation (RT) + 30 min. (RT) + 10 min. (RT) = 1 hour, 40 min. total incubation time
Catalog number:
TM09011
configuration:
96 Determinations, 12x8 removable strips
controls:
None provided
design:
Enzyme immunoassay (ELISA) technique
FDA Status:
For research use only, not for use in diagnostic procedures
MSDS:
Available upon request
notes:
The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
Protocol:

Protocol

Sample types:
Serum and plasma
Sample volume:
10 µL
standards:
5 standards, ready to use
Standard range:
0 / 6 - 200 ng/mL
storage:
2 - 8 °C
sensitivity:
2 ng/mL
Species:
Human
Products related:
Anti-Bevacizumab (Avastin®) ELISA
Bevacizumab (Avastin®) ELISA
Additional info:

Pamphlet